Compounds and methods of use for treatment of neurogenic inflammation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 8, 2003
Grant Date -
Feb 7, 2002
app pub date -
Aug 31, 2001
filing date -
Feb 20, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The subject invention pertains to compounds which are useful as anti-inflammatory agents and to compositions containing such compounds as active ingredients. The novel uses of the compounds relate to the anti-neurogenic inflammatory properties of the disclosed bis-heterocyclic compounds. Specifically exemplified herein are dragmacidin f, topsentin d, and topsentin e, and their salts, analogs, and derivatives.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully